Mainstream

Imunon outlines rapid OVATION 3 Phase III trial launch and initiates 15% stock dividend to support shareholder value

Imunon outlines rapid OVATION 3 Phase III trial launch and initiates 15% stock dividend to support shareholder value

Post ContentimnnRead More

You might also be interested in reading SideChannel targets growth with Enclave software expansion and international sales push.

August 5, 2025
In Mainstream